Beijing Biostar Pharmaceuticals (02563) Announces November 2025 Monthly Return on Securities Movements

Bulletin Express
2025/12/03

Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 02563) released its monthly return for the period ended 30 November 2025. The company’s total registered share capital remains RMB 364,588,000, comprising 216,720,857 H shares listed on the Hong Kong Stock Exchange and 147,867,143 unlisted shares, each with a par value of RMB 1.

The announcement indicates no changes to the issued share capital during the reporting month. Both categories of shares maintained the same balance as at the close of the preceding month. No share options, warrants, convertible securities, or other arrangements affected the company’s share capital within this period. The document was submitted on 03 December 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10